From: Treatment resistant schizophrenia: a comprehensive survey of randomised controlled trials
Name of intervention | Number | Cochrane review | |
---|---|---|---|
Studies | Participants | ||
Antipsychotics | Â | ||
  Amisulpride | 4 | 322 | [21] |
  Aripiprazole | 5 | 349 |  |
  Fluphenazine | 1 | 60 |  |
  Haloperidol | 2 | 116 |  |
  Paliperidone | 1 | 70 |  |
  Pipotiazine | 1 | 84 |  |
  Quetiapine | 2 | 136 | [21] |
  Risperidone | 10 | 646 | [21] |
  Sertindole | 1 | 50 |  |
  Sulpride | 2 | 150 | |
  Ziprasidone | 3 | 150 | [21] |
  Clozapine added to 'other antipsychotics' | 2 | 100 |  |
Antidepressants | Â | ||
  Duloxetine | 1 | 33 |  |
  Fluvoxamine | 1 | 68 |  |
Anticonvulsants/mood stabilisers | Â | ||
  Valproate | 1 | 34 | [23]* |
  Lamotrigine | 2 | 85 | [24]* |
  Lithium | 3 | 152 | [25]* |
Antimicrobials | Â | ||
  Inosine | 1 | 66 |  |
Herbal | Â | ||
  Ginkgo Biloba | 1 | 42 |  |
Anti-diabetic | Â | ||
Metformin | 1 | 61 | Â |
Selective norepinephrine reuptake inhibitor | Â | ||
  Atomoxetine | 1 | 126 |  |
Drugs Used in Dementia | Â | ||
  Mematine | 1 | 21 | [26]** |
Amino acids | Â | ||
  Glycine | 2 | 31 | [27]* |